TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,380,725 | +3228.4% | 153,893 | +3280.0% | 0.01% | – |
| Q2 2023 | $71,528 | -91.5% | 4,553 | -91.1% | 0.00% | -100.0% |
| Q1 2023 | $840,958 | -49.9% | 51,029 | -52.6% | 0.00% | -50.0% |
| Q4 2022 | $1,679,839 | -62.9% | 107,682 | -65.9% | 0.00% | -42.9% |
| Q1 2022 | $4,522,000 | +5.1% | 315,800 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $4,304,000 | -57.3% | 315,800 | -48.6% | 0.01% | -59.1% |
| Q3 2021 | $10,069,000 | -25.5% | 614,700 | -23.5% | 0.02% | -40.5% |
| Q2 2021 | $13,521,000 | -31.3% | 803,400 | -25.4% | 0.04% | -49.3% |
| Q1 2021 | $19,676,000 | +192.9% | 1,077,507 | +191.9% | 0.07% | +170.4% |
| Q4 2020 | $6,718,000 | +11482.8% | 369,120 | +11331.4% | 0.03% | – |
| Q3 2020 | $58,000 | -80.3% | 3,229 | -80.3% | 0.00% | -100.0% |
| Q2 2020 | $294,000 | – | 16,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |